Valuation: DEEPVERGE

Market Cap 8.75M 7.83M 7.2M 6.53M 12.2M 830M 12.43M 85.91M 34.49M 437M 32.82M 32.12M 1.38B P/E 2020
-12.5x
P/E 2021 -19.3x
Enterprise Value 9.18M 8.22M 7.56M 6.85M 12.81M 872M 13.05M 90.18M 36.2M 458M 34.45M 33.72M 1.45B EV / Sales 2020
10x
EV / Sales 2021 6.11x
Free-Float
90.54%
Yield 2020 *
-
Yield 2021 -
5 years 0
Extreme 0.0005
0.34
10 years 0
Extreme 0.0005
0.42
Manager TitleAgeSince
Chief Executive Officer 68 01/11/2022
Director of Finance/CFO - 30/08/2018
Sales & Marketing 53 12/07/2021
Director TitleAgeSince
Chairman 66 21/05/2019
Director/Board Member 68 10/11/2020
Date Insider Type Main position Quantity % Market Cap. Importance
11/16/22 A Free

Executive/Senior Manager

162,500 0.0740%
11/16/22 A Buy

Chief Financial Officer

2,000,000 0.9103%
11/16/22 A Buy

Executive/Senior Manager

650,000 0.2958%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%-.--%-.--% 421K
+0.74%-0.18%+21.19%+80.39% 763B
+0.80%-1.88%+19.53%+77.13% 86.59B
-2.39%+5.31%+34.37%+193.23% 74.22B
-10.38%-3.16%+23.21%+713.83% 47.14B
+0.11%-0.91%-18.18%+13.14% 47.31B
-0.95%-3.54%-0.38%+90.45% 46.52B
-0.82%+6.04%+22.00%+45.93% 34.55B
+0.75%-3.39%+49.54%+80.68% 26.13B
+3.18%-1.57%-29.15%-55.52% 25.78B
Average -0.74%+0.69%+12.21%+123.93% 115.16B
Weighted average by Cap. +0.27%-0.11%+19.05%+106.92%

Financials

2020 2021
Net sales 4.48M 4.01M 3.69M 3.35M 6.26M 426M 6.37M 44.04M 17.68M 224M 16.82M 16.47M 706M 9.3M 8.33M 7.66M 6.94M 12.97M 883M 13.21M 91.33M 36.66M 464M 34.89M 34.15M 1.46B
Net income -2.72M -2.43M -2.24M -2.03M -3.79M -258M -3.86M -26.7M -10.72M -136M -10.2M -9.98M -428M -2.68M -2.4M -2.21M -2M -3.74M -254M -3.81M -26.32M -10.57M -134M -10.05M -9.84M -422M
Net Debt 1.11M 997K 917K 831K 1.55M 106M 1.58M 10.93M 4.39M 55.59M 4.18M 4.09M 175M 434K 389K 358K 324K 606K 41.21M 617K 4.26M 1.71M 21.68M 1.63M 1.59M 68.36M
Logo DEEPVERGE
Deepverge PLC is an Ireland-based vertically integrated company. The Company provides core skin and human testing technology. The Company is engaged in collaborating technology platforms with partners in artificial intelligence (AI), clinical research, medical device, life science and environmental science. Its Labskin delivers human skin microbiology services to support product R&D activities in the cosmetic, personal care, medical device and pharmaceutical sectors. The Labskin model is a 3D human skin equivalent that incorporates vital biological components to model normal skin function. It allows skin-care, health-care, nutritional, pharmaceutical manufacturers and cosmetic companies to test consumer products on human-like skin in a real-world environment with full access to multiple partner technologies.
Employees
73